LLY

Eli Lilly & Co
D

LLY

Arincen80/100B

Eli Lilly & Co earnings

Eli Lilly & Co reports its Q4 FY2026 results on 3 February 2027, before the market opens. Analysts expect earnings per share of 11.19 USD and revenue of 24.58B USD.

In Q3 FY2026, reported on 29 October 2026, Eli Lilly & Co earned 7.48 USD a share against the 5.71 USD analysts expected (+31.0%), on revenue of 24.40B USD against 22.58B USD (+8.0%).

Last EPS surprise
+31.0%
Last revenue surprise
+8.0%
Move after the last report
+6.5%
Average move after earnings
2.5%

EPS and revenue against estimates

Next earnings · Q4 FY2026
EPS estimate
11.19 USD
Revenue estimate
24.58B USD
Last quarter · Q3 FY2026
EPS7.48Beat +31.0%Revenue24.40BBeat +8.0%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growthNext-day move
Q1 FY202710.93——+27.89%23.62B——+19.31%—
Q4 FY202611.19——+48.41%24.58B——+27.42%—
Q3 FY20265.717.48+31.00%+6.55%22.58B24.40B+8.03%+38.61%+6.5%
Q2 FY20266.408.38+30.94%+32.81%20.82B22.97B+10.33%+47.67%+4.7%
Q1 FY20266.978.55+22.67%+155.99%17.82B19.80B+11.11%+55.55%+9.8%
Q4 FY20256.917.54+9.12%+41.73%17.94B19.29B+7.51%+42.56%+10.5%
Q3 FY20255.697.02+23.37%+494.92%16.05B17.60B+9.64%+53.87%+3.8%
Q2 FY20255.606.31+12.68%+60.97%14.70B15.56B+5.80%+37.64%-14.2%
Q1 FY20253.263.34+2.45%+29.46%12.67B12.73B+0.48%+45.17%-11.5%
Q4 FY20245.035.32+5.77%+113.65%—13.53B—+44.68%+3.4%
Q3 FY20241.471.18-19.73%+1,080.00%12.10B11.44B-5.44%+20.43%-6.3%
Q2 FY20242.603.92+50.77%+85.78%9.98B11.30B+13.24%+35.98%+9.2%
Q1 FY20242.462.58+4.88%+59.26%8.94B8.77B-1.88%+25.98%+6.0%
Q4 FY20232.222.49+12.16%+19.14%8.93B9.35B+4.71%+28.10%-0.1%
Q3 FY2023-0.080.10+225.00%-94.95%8.95B9.50B+6.08%+36.84%+4.6%
Q2 FY20231.982.11+6.57%+68.80%7.58B8.31B+9.62%+28.11%+14.8%
Q1 FY20231.731.62-6.36%-38.17%7.55B6.96B-7.83%-10.88%+3.8%
Q4 FY20221.782.09+17.42%-16.06%7.33B7.30B-0.42%-8.73%-3.5%
Q3 FY20221.921.98+3.13%+2.06%6.89B6.94B+0.78%+2.49%-2.6%
Q2 FY20221.691.25-26.04%-33.16%6.85B6.49B-5.27%-3.74%-2.5%
Q1 FY20222.322.62+12.93%+40.11%7.29B7.81B+7.18%+14.76%+4.4%
Q4 FY20212.512.49-0.80%-9.45%7.69B8.00B+4.06%+7.53%-2.5%
Q3 FY20211.981.94-2.02%+25.97%6.57B6.77B+3.08%+17.98%+1.4%
Q2 FY20211.891.87-1.06%-1.06%6.74B6.74B0.00%+22.56%+3.7%
Q1 FY20212.121.87-11.79%+6.86%7.64B6.81B-10.88%+16.14%-2.8%
Q4 FY20202.352.75+17.02%+58.96%6.17B7.44B+20.51%+21.69%-1.3%
Q3 FY20201.711.54-9.94%+4.05%6.37B5.74B-9.93%+4.82%-7.0%
Q2 FY20201.561.89+21.15%+26.00%4.54B5.50B+21.15%-2.44%-5.5%
Q1 FY20201.481.75+18.24%+31.58%4.96B5.86B+18.24%+15.07%+2.2%
Q4 FY20191.521.73+13.82%+30.08%5.37B6.11B+13.82%-5.04%+1.9%
Q3 FY20191.411.48+4.96%+6.47%5.22B5.48B+4.96%+3.20%-2.3%
Q2 FY20191.451.50+3.45%0.00%5.45B5.64B+3.45%+0.93%-0.0%
Q1 FY20191.321.33+0.76%-0.75%5.02B5.09B+1.53%+2.59%-2.1%
Q4 FY20181.341.33-0.75%+16.67%5.68B6.44B+13.36%+4.51%-1.0%
Q3 FY20181.351.39+2.96%+32.38%5.15B5.31B+2.96%-6.21%-4.3%
Q2 FY20181.311.50+14.50%+35.14%4.84B5.59B+15.38%-4.11%+5.0%
Q1 FY20181.131.34+18.58%+36.73%4.19B4.96B+18.58%-5.06%-0.1%
Q4 FY20171.081.14+5.56%+20.00%5.78B6.16B+6.54%+6.95%-5.4%
Q3 FY20171.031.05+1.94%+19.32%5.55B5.66B+1.94%+8.98%-2.3%
Q2 FY20171.051.11+5.71%+29.07%5.51B5.82B+5.71%+7.76%-3.1%
Q1 FY20170.960.98+2.08%+18.07%5.12B5.23B+2.08%+7.47%-2.7%
Q4 FY20160.990.95-4.04%+21.79%5.94B5.76B-3.06%+7.16%+3.2%
Q3 FY20160.960.88-8.33%-1.12%5.66B5.19B-8.33%+4.68%+0.4%
Q2 FY20160.860.860.00%-4.44%5.40B5.40B0.00%+8.56%+0.1%
Q1 FY20160.850.83-2.35%-4.60%4.98B4.87B-2.35%+4.75%-2.1%
Q4 FY20150.770.78+1.30%+4.00%5.38B5.38B0.00%+4.97%-6.1%
Q3 FY20150.760.89+17.11%+34.85%4.24B4.96B+17.11%+1.72%-0.0%
Q2 FY20150.740.90+21.62%+32.35%4.09B4.98B+21.62%+0.87%+0.4%
Q1 FY20150.760.87+14.47%+24.29%4.11B4.64B+12.99%-0.82%+0.1%
Q4 FY20140.740.75+1.35%+1.35%5.05B5.12B+1.35%-11.84%-0.2%
Q3 FY20140.660.660.00%-40.54%4.95B4.88B-1.49%-15.54%-0.5%
Q2 FY20140.650.68+4.62%-41.38%4.72B4.94B+4.62%-16.76%+0.2%
Q1 FY20140.700.700.00%-38.60%4.68B4.68B0.00%-16.40%-1.5%
Q4 FY20130.740.740.00%-12.94%5.81B5.81B0.00%-2.49%-1.2%
Q3 FY20131.041.11+6.73%+40.51%5.41B5.77B+6.73%+6.05%+0.3%
Q2 FY20131.001.16+16.00%+39.76%5.11B5.93B+16.00%+5.87%+3.1%
Q1 FY20131.051.14+8.57%+23.91%5.16B5.60B+8.57%0.00%-3.9%
Q4 FY20120.780.85+8.97%-2.30%5.47B5.96B+8.97%-1.48%+3.2%
Q3 FY20120.830.79-4.82%-30.09%5.72B5.44B-4.82%-11.46%-2.7%
Q2 FY20120.770.83+7.79%-29.66%5.20B5.60B+7.79%-10.43%+2.7%
Q1 FY20120.780.92+17.95%-25.81%4.75B5.60B+17.95%-4.06%+2.1%
Q4 FY20110.810.87+7.41%-21.62%5.63B6.05B+7.41%-2.27%+1.2%
Q3 FY20111.131.130.00%-6.61%6.15B6.15B0.00%+8.72%-0.2%
Q2 FY20111.181.180.00%-4.84%6.25B6.25B0.00%+8.77%+3.0%
Q1 FY20111.171.24+5.98%+5.08%5.51B5.84B+5.98%+6.45%-1.1%
Q4 FY20101.101.11+0.91%+21.98%6.13B6.19B+0.91%+4.26%+1.5%
Q3 FY20101.151.21+5.22%+0.83%5.37B5.65B+5.22%+1.67%-1.4%
Q2 FY20101.101.24+12.73%+10.71%5.10B5.75B+12.73%+8.61%+0.6%
Q1 FY20101.101.18+7.27%-1.67%5.11B5.49B+7.27%+8.69%+0.1%
Q4 FY20090.920.91-1.09%-14.95%6.00B5.93B-1.09%+13.89%-1.8%
Q3 FY20091.021.20+17.65%+15.38%4.73B5.56B+17.65%+6.77%-4.5%
Q2 FY20091.021.12+9.80%+13.13%4.82B5.29B+9.80%+2.76%-1.9%
Q1 FY20090.991.20+21.21%+30.43%4.16B5.05B+21.21%+4.98%-2.3%
Q4 FY20081.051.07+1.90%+18.89%5.11B5.21B+2.02%+0.40%-2.9%
Q3 FY20081.021.04+1.96%+14.29%5.11B5.21B+1.96%+13.58%+4.3%
Q2 FY20081.000.99-1.00%+10.00%5.20B5.15B-1.00%+11.22%+0.8%
Q1 FY20080.960.92-4.17%+9.52%5.02B4.81B-4.17%+13.76%-4.8%
Q4 FY20070.890.90+1.12%+5.88%5.13B5.19B+1.12%+22.24%+1.8%
Q3 FY20070.870.91+4.60%+13.75%4.39B4.59B+4.60%+18.70%-0.5%
Q2 FY20070.820.90+9.76%+18.42%4.22B4.63B+9.76%+19.76%0.0%
Q1 FY20070.790.84+6.33%+9.09%3.97B4.23B+6.33%+13.77%+2.7%
Q4 FY20060.820.85+3.66%+6.25%4.10B4.25B+3.66%+9.44%+2.6%
Q3 FY20060.790.80+1.27%+9.59%3.82B3.86B+1.27%+7.30%-1.3%
Q2 FY20060.750.76+1.33%+13.43%3.82B3.87B+1.33%+5.43%-2.9%
Q1 FY20060.750.77+2.67%+13.24%3.62B3.71B+2.67%+6.21%-1.9%
Q4 FY20050.780.80+2.56%+6.67%3.78B3.88B+2.63%+6.44%-0.4%
Q3 FY20050.710.73+2.82%+5.80%3.50B3.60B+2.82%+9.78%-0.7%
Q2 FY20050.670.670.00%-1.47%3.67B3.67B0.00%+3.13%-1.8%
Q1 FY20050.660.68+3.03%-2.86%3.39B3.50B+3.03%+3.57%+1.6%
Q4 FY20040.740.75+1.35%+11.94%3.60B3.64B+1.37%+5.16%+1.2%
Q3 FY20040.680.69+1.47%+4.55%3.23B3.28B+1.47%+4.49%-4.5%
Q2 FY20040.680.680.00%+6.25%3.56B3.56B0.00%+15.16%-0.8%
Q1 FY20040.660.70+6.06%+14.75%3.18B3.38B+6.06%+16.87%+1.3%
Q4 FY20030.670.670.00%-1.47%3.47B3.47B0.00%+17.25%+2.2%
Q3 FY20030.660.660.00%-2.94%3.14B3.14B0.00%+12.70%-2.8%
Q2 FY20030.600.64+6.67%+4.92%2.90B3.09B+6.67%+11.28%+1.1%
Q1 FY20030.580.61+5.17%+5.17%2.75B2.89B+5.17%+12.82%+3.1%
Q4 FY20020.680.680.00%+13.33%2.96B2.96B0.00%+4.48%-2.2%
Q3 FY20020.680.680.00%+3.03%2.79B2.79B0.00%-3.09%-7.8%
Q2 FY20020.610.610.00%-19.74%2.78B2.78B0.00%-8.51%-4.6%
Q1 FY20020.580.580.00%-21.62%2.56B2.56B0.00%-8.72%+2.4%
Q4 FY20010.600.600.00%-14.29%2.83B2.83B0.00%-5.00%-2.2%
Q3 FY20010.660.660.00%-7.04%2.87B2.87B0.00%+2.22%+1.5%
Q2 FY20010.740.76+2.70%+24.59%2.95B3.03B+2.70%+15.72%+0.9%
Q1 FY20010.730.74+1.37%+17.46%2.77B2.81B+1.37%+14.47%+2.0%
Q4 FY20000.700.700.00%+14.75%2.98B2.98B0.00%+5.57%+0.4%
Q3 FY20000.710.710.00%+14.52%2.81B2.81B0.00%+8.77%-0.8%
Q2 FY20000.600.61+1.67%+17.31%2.58B2.62B+1.67%+11.95%-4.5%
Q1 FY20000.610.63+3.28%+18.87%2.37B2.45B+3.28%+8.67%+3.8%
Q4 FY19990.610.610.00%+22.00%2.82B2.82B0.00%+37.33%+2.4%
Q3 FY19990.620.620.00%+16.98%2.59B2.59B0.00%+9.57%-6.1%
Q2 FY19990.510.52+1.96%+15.56%2.30B2.34B+1.96%+8.66%-1.1%
Q1 FY19990.530.530.00%+12.77%2.26B2.26B0.00%+8.08%-11.5%
Q4 FY19980.510.50-1.96%+21.95%2.09B2.05B-1.92%-14.98%+1.7%
Q3 FY19980.510.53+3.92%+29.27%2.27B2.36B+3.92%+9.23%+3.5%
Q2 FY19980.430.45+4.65%+18.42%2.06B2.16B+4.65%+8.36%+0.5%
Q1 FY19980.460.47+2.17%+14.63%2.04B2.09B+2.17%+6.86%+5.6%
Q4 FY19970.420.41-2.38%+20.59%2.47B2.42B-2.33%+17.21%-0.3%
Q3 FY19970.400.41+2.50%+7.89%2.11B2.16B+2.50%+19.75%+3.0%
Q2 FY19970.380.380.00%+18.75%1.99B1.99B0.00%+17.10%+2.0%
Q1 FY19970.400.41+2.50%+13.89%1.91B1.95B+2.50%+9.52%+0.1%
Q4 FY19960.340.340.00%+21.43%2.06B2.06B0.00%+14.52%-2.7%
Q3 FY19960.320.38+18.75%+40.74%—1.80B—+10.54%+0.7%
Q2 FY19960.320.320.00%+18.52%—1.70B—+5.17%-4.2%
Q1 FY19960.360.360.00%+9.09%—1.78B—+3.84%-2.0%
Q4 FY19950.280.280.00%+21.74%—1.80B—+211.01%+4.2%
Q3 FY19950.270.270.00%-12.90%—1.63B—-10.21%-0.4%
Q2 FY19950.270.270.00%-12.90%—1.61B—-3.80%+0.8%
Q1 FY19950.320.33+3.13%+3.13%—1.72B—+4.91%0.0%
Q4 FY19940.270.23-14.81%-17.86%—578.70M—-67.86%-1.0%
Q3 FY19940.290.31+6.90%+24.00%—1.82B—+18.74%+0.4%
Q2 FY19940.300.31+3.33%+3.33%—1.68B—+7.53%-0.2%
Q1 FY19940.310.32+3.23%0.00%—1.64B—+4.94%+2.6%
Q4 FY19930.290.28-3.45%+4.79%—1.80B—+8.78%-1.7%
Q3 FY19930.240.25+4.17%——1.53B——-2.8%
Q2 FY19930.300.300.00%+3.45%—1.56B—+5.59%+1.0%
Q1 FY19930.310.32+3.23%——1.56B——+3.3%
Q4 FY19920.290.290.00%+8.53%—1.48B—-6.11%+1.5%
Q4 FY1992—0.27—0.00%—1.66B—+5.27%-1.6%
Q2 FY1992—0.29—+7.41%—1.48B—+7.41%-1.0%
Q4 FY1991—0.38—+68.74%—1.56B—+7.85%+1.6%
Q4 FY1991—0.27—+18.65%—1.57B—+8.92%-1.6%
Q3 FY1991—0.26—+13.04%—1.34B—+4.64%+0.7%
Q2 FY1991—0.27—+12.50%—1.38B—+12.31%+2.8%
Q4 FY1990—0.34—+72.94%—1.44B—+83.10%+1.3%
Q4 FY1990—0.23—+14.55%—1.44B—+84.16%+1.7%
Q3 FY1990—0.23—+21.05%—1.28B—+22.65%+4.5%
Q2 FY1990—0.24—+26.32%—1.23B—+9.26%+0.6%
Q4 FY1989—0.29—+84.48%—1.24B—+19.03%+0.2%
Q4 FY1989—0.20—+25.06%—784.00M—-24.78%+0.4%
Q3 FY1989—0.19—+21.79%—1.05B—+11.11%-1.2%
Q2 FY1989—0.19—+16.14%—1.12B—+10.53%-0.2%
Q4 FY1988—0.26———1.23B—+100.98%+0.7%
Q4 FY1988—0.16———1.04B—+71.01%+0.1%
Q3 FY1988—0.16—+15.99%—940.60M—-1.79%-1.3%
Q2 FY1988—0.16—+21.10%—1.01B—-0.28%+2.4%
Q4 FY1987—0.21—+84.15%—1.07B—+10.59%-0.6%
Q4 FY1987—-0.08—-173.86%—609.50M—-37.13%-0.5%
Q3 FY1987—0.13—+10.70%—957.70M—+8.41%-0.5%
Q2 FY1987—0.14—+19.98%—1.02B—+15.73%-1.5%
Q4 FY1986—0.18—+64.29%—1.06B—+29.62%-1.0%
Q4 FY1986—0.11—+1.16%—969.40M—+18.65%-0.9%
Q3 FY1986—0.12—+11.26%—883.40M—+12.12%-0.2%
Q2 FY1986—0.11———879.30M——+1.6%
Q4 FY1985—0.15———988.30M——-1.4%
Q4 FY1985—0.11———817.00M——+0.4%
Q3 FY1985—0.11———787.90M——+0.4%

The move is the shares' change on the trading day after the report: after a report after the close, the next day's close on the report day's; before the open, the report day's close on the day before's. Surprise is the reported figure against the analysts' average estimate.

Q4 FY2026

What the market is waiting for

From the last earnings call, the company's guidance and analysts' previews, and checked against the report when it comes.

High importanceWaiting for 3 Feb

Next year's sales outlook

Expected2027 revenue guidance of about $102 billionanalysts' consensus
The resultComes with the report on 3 Feb

The outlook will show how much growth Lilly expects as its obesity and diabetes medicines reach more patients.

Beat record

On average, analysts' EPS estimate was 18.8% off the result, either way, and their revenue estimate 7.1%, over the last 12 quarters.

EPS beats
86 / 136
Revenue beats
78 / 119
Average EPS surprise, last 12
+15.5%
Since
February 1993

See also:Forecast,EPS,Income statement

Common questions about Eli Lilly & Co's earnings

Source: Financial Modeling Prep